On Jan. 14, 2021, China National Medical Products Administration (NMPA) held a news briefing on Cosmetic Supervision and Administration Regulation (CSAR) implementation.  During the briefing, the following three officials answered several questions about CSAR implementation.
Liubin Qi, Deputy Director of the Department of Cosmetics Regulation of NMPA;
Qingbin Lin, Researcher of the Division of Supervision I; and
Yunfeng Li, Division Chief of the Division of Supervision II.
ChemLinked summarizes the key points as follows.